Enclomiphene Overview
Enclomiphene is an oral medication that raises testosterone by stimulating your body's natural production rather than replacing it with synthetic hormones. It's the purified trans-isomer of clomiphene, functioning as a selective estrogen receptor modulator (SERM) that blocks estrogen's negative feedback signal to your brain1. You take it as a daily tablet — no injections, no skin patches.
Enclomiphene is not FDA-approved for testosterone replacement therapy. The brand name Androxal failed to gain FDA approval in 2019 despite positive clinical trial data2. Today, it's available exclusively through compounding pharmacies as an off-label treatment for secondary hypogonadism.
This drug targets men who want to raise testosterone while preserving fertility. Because it works by boosting your natural hormone production, your testes keep functioning — spermatogenesis continues, testicular size remains normal, and you stay fertile3. That makes enclomiphene particularly attractive to younger men or anyone planning to have children.
The medication works best for secondary hypogonadism — men whose testes can still produce testosterone but aren't getting the right signals from the pituitary gland. It won't help primary hypogonadism (direct testicular failure), where the issue lies in the testes themselves.
Enclomiphene at a Glance
Enclomiphene is an oral SERM that raises testosterone by blocking estrogen feedback to the pituitary, stimulating natural LH and FSH production.
It preserves fertility and testicular function, making it ideal for younger men or anyone planning to have children.
- Mechanism: Blocks estrogen receptors in the hypothalamus, increasing LH/FSH release and testicular testosterone production
- Dosing: 12.5-25 mg daily oral tablet, adjust based on labs every 4-6 weeks
- Safety: Generally well-tolerated; monitor estradiol, avoid if you have primary hypogonadism or liver disease
- Cost: $80-200/month from compounding pharmacies; not covered by insurance
How Enclomiphene Works
The magic happens in your hypothalamus and pituitary gland. Enclomiphene competes with estrogen for binding sites on estrogen receptors, effectively blocking estrogen's inhibitory signal to the brain4. In a normal hormonal feedback loop, estrogen tells your hypothalamus to dial down testosterone production — enclomiphene removes that brake.
When estrogen receptors in the hypothalamus stay blocked, your brain increases production of gonadotropin-releasing hormone (GnRH). That GnRH surge triggers your pituitary to release more luteinizing hormone (LH) and follicle-stimulating hormone (FSH)4. The elevated LH directly stimulates Leydig cells in your testes to ramp up testosterone synthesis. Meanwhile, the FSH boost supports sperm production — this is why fertility stays intact.
You'll feel effects within 2-4 weeks of starting treatment. Peak serum concentration happens 2-3 hours after you swallow the tablet, and the drug has a half-life of approximately 10 hours2. Despite that short half-life, testosterone elevation persists for at least 7 days after you stop taking enclomiphene — researchers believe this "legacy effect" comes from sustained estrogen receptor blockade on the HPG axis, not lingering drug levels.
Clinical Trial Data
The pivotal phase II trial by Wiehle et al. enrolled 48 men with baseline testosterone below 350 ng/dL and demonstrated that enclomiphene increased testosterone while simultaneously raising FSH and LH levels2. Critically, spermatogenesis was preserved throughout treatment — the key differentiator from exogenous testosterone therapy.
Maximum benefit occurred at 25 mg daily dosing. Lower doses produced less consistent testosterone elevation, while higher doses didn't improve outcomes. The study confirmed steady-state levels were achieved non-dose-dependently, suggesting a therapeutic ceiling effect.
How It Compares to Alternatives
Enclomiphene differs fundamentally from exogenous testosterone (injections, gels, pellets). Testosterone replacement shuts down your natural production — your pituitary stops releasing LH and FSH, your testes shrink, and sperm production grinds to a halt. Enclomiphene does the opposite: it amplifies your body's signals to produce more testosterone.
Enclomiphene is the purified trans-isomer of clomiphene citrate. Standard clomiphene contains both the trans-isomer (enclomiphene) and cis-isomer (zuclomiphene), and that mix causes problems. Zuclomiphene acts as an estrogen agonist with a longer half-life, producing estrogenic side effects like gynecomastia and mood swings5. Pure enclomiphene avoids those issues by eliminating the agonist isomer entirely.
Gonadotropin-Releasing Hormone (GnRH) is a hormone produced by the hypothalamus that stimulates the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which control testosterone production and sperm formation.
HPG Axis refers to the hypothalamic-pituitary-gonadal system, the interconnected hormonal pathway controlling testosterone and reproductive function through communication between the brain and testes.
Dosing & Administration
You take enclomiphene as a daily oral tablet, typically in the morning with or without food. Most protocols start at 12.5 mg daily, then adjust based on lab results and symptom response. The target is getting testosterone into the 500-900 ng/dL range while keeping estradiol controlled.
The table below outlines standard dosing and monitoring protocols used by clinics prescribing compounded enclomiphene for secondary hypogonadism.
| Parameter | Standard Protocol | Clinical Notes |
|---|---|---|
| Starting Dose | 12.5 mg daily | Some clinics start at 25 mg if baseline T is very low (<250 ng/dL) |
| Frequency | Once daily, morning preferred | Take at same time each day for consistent levels |
| Titration | Adjust after 4-6 weeks based on labs | Increase to 25 mg if T remains <400 ng/dL; rarely go above 25 mg |
| Baseline Labs | Total T, Free T, Estradiol, LH, FSH, SHBG | Draw in morning (7-10 AM) when T peaks naturally |
| Follow-Up Labs | 4-6 weeks, then quarterly | Monitor for estradiol elevation; some men need an AI if E2 climbs too high |
| Duration | Ongoing; no defined time limit | Most clinics monitor long-term safety with liver enzymes and lipids annually |
Dosing is straightforward, but monitoring matters. Your body's testosterone response depends on how well your testes can still function, so lab results dictate dose adjustments. If testosterone climbs but estradiol spikes too high, some clinics add a low-dose aromatase inhibitor.
Side Effects & Safety
Enclomiphene is generally well-tolerated, with most side effects mild and transient. The absence of zuclomiphene (the estrogenic isomer in clomiphene) reduces the risk of gynecomastia and mood disturbances compared to mixed clomiphene preparations5.
Common issues are headache, nausea, and mood changes — usually mild and resolving within the first month. Rare but serious risks include blood clots and visual disturbances, though these are more commonly associated with clomiphene citrate than pure enclomiphene.
| Frequency | Side Effect | Clinical Management |
|---|---|---|
| Common (>10%) | Headache, nausea | Usually resolves within 2-3 weeks; take with food if nausea persists |
| Occasional (1-10%) | Mood swings, irritability | Monitor estradiol — high E2 can worsen mood; adjust dose or add AI |
| Occasional (1-10%) | Acne, oily skin | Related to rising testosterone; treat symptomatically |
| Rare (<1%) | Visual disturbances (blurred vision, floaters) | Stop drug immediately and refer to ophthalmology |
| Rare (<1%) | Thromboembolic events | Highest risk in men with clotting disorders or recent surgery |
Long-Term Safety Considerations
Enclomiphene lacks long-term safety data beyond 2-3 years of use. The Androxal trials followed men for up to 18 months without major safety signals, but multi-year outcomes remain unknown. Most clinics monitor liver enzymes and lipid panels annually as a precaution.
Because enclomiphene raises estradiol along with testosterone, some men develop high E2 symptoms (water retention, emotional sensitivity, nipple tenderness). If estradiol climbs above 40-50 pg/mL, your provider may add a low-dose aromatase inhibitor or reduce your enclomiphene dose.
Cost & Access
Enclomiphene runs $80-200 per month through compounding pharmacies, depending on dose and pharmacy markup. Because it's not FDA-approved for TRT, insurance won't cover it — you're paying out of pocket.
Most telehealth TRT clinics offer enclomiphene as part of their fertility-focused protocols. Monthly cost typically includes the medication, provider consultation, and lab ordering (though you pay separately for the actual blood draws). Some clinics bundle enclomiphene with other fertility-supportive compounds like HCG or low-dose anastrozole.
Compounding pharmacies are your only source. You can't get brand-name Androxal because it never reached market, and generic pharmaceutical-grade enclomiphene doesn't exist in the U.S. That means quality varies by compounder — reputable clinics use pharmacies with third-party testing and stability data.
Local men's health clinics and urologists rarely prescribe enclomiphene because most prefer FDA-approved medications. Your best bet is a telehealth provider specializing in fertility-friendly TRT alternatives. Expect to pay $100-150 for the initial consult, then $50-100 per follow-up visit every 3-6 months.